Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats

Fundamental and Clinical Pharmacology

Volumn 18, Issue 1, 2004, Pages 33-38

  Xu, Li Ping ^a   Shen, Fu Ming ^a   Shu, He ^a   Miao, Chao Yu ^a   Jiang, Yúan Ying ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Amlodipine; Atenolol; Blood pressure; Blood pressure variability; Hypertension

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CARBOXYMETHYLCELLULOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CATHETER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; DRUG RESPONSE; EXPERIMENTAL MODEL; FEMALE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AMLODIPINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DRUG SYNERGISM; FEMALE; HYPERTENSION; MALE; RATS; RATS, INBRED SHR;

EID: 1042288135     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00200.x     Document Type: Article

References (31)

1. Manda G., Ferrari A., Gregorini L. et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Cir. Res. (1983) 53 96-104.
2. Su D.F., Cerutti C., Barres C., Vincent M., Sassard J. Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. Am. J. Physiol. (1986) 251 H1111-H1117.
3. Miao C.Y., Shen P.M., Su D.F. Blood pressure variability is increased in genetic hypertension and L-NAME-induced hypertension. Acta Pharmacol. Sin. (2001) 22 137-140.
4. Parati G., Pomidossi G., Albini F., Malaspina D., Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J. Hypertens. (1987) 5 93-98.
5. Mancia G., Frattola A., Parati G., Santucciu C., Ulian L. Blood pressure variability and organ damage. J. Cardiovasc. Pharmacol. (1994) 24 S6-S11.
6. Su D.F., Miao C.Y. Blood pressure variability and organ damage. Clin. Exp. Pharmacol. Physiol. (2001) 28 709-715.
7. Du W.M., Miao C.Y., Liu J.G., Shen F.M., Yang X.Q., Su D.F. Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. (2003) 41 233-239.
8. Xie H.H., Miao C.Y., Liu J.G., Su D.F. Importance of blood pressure variability in organ protection in spontaneously hypertensive rats treated with combination of nitrendipine and atenolol. Acta Pharmacol. Sin. (2002) 23 1199-1204.
9. Lu Z.A., Xie H.H., Xu L.P., Yin A.F., Miao C.Y., Su D.F. Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with long-term hydrochlorothiazide mixture. Clin. Exp. Pharmacol. Physiol. (2003) 30 49-54.
10. Materson B.J., Reda D.J., Cushman W.C. et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N. Engl. J. Med. (1993) 328 914-921.
11. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. (1997) 157 2413-2446.
12. Su D.F., Chen L., Kong X.B., Cheng Y. Determination of arterial baroreflex-blood pressure control in conscious rats. Acta Pharmacol. Sin. (2002) 23 103-109.
13. Miao C.Y., Zhu Q.Y., Yang Y.C., Su D.F. Antihypertensive effects of atenolol and nitrendipine alone or in combination on three hypertensive models of rats. Acta Pharmacol. Sin. (1992) 13 448-451.
14. Jin Z.J. Addition in drug combination. Acta Pharmacol. Sin. (1980) 1 70-76.
15. Eisen S.A., Miller D.K., Woodward R.S., Spitznagel E., Przybeck T.R. The effect of prescribed daily dose frequency on patient medication compliance. Arch. Intern. Med. (1990) 150 1881-1884.
16. Sica D.A. Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy? Drugs (1994) 48 16-24.
17. Prisant L.M. Fixed low-dose combination in first-line treatment of hypertension. J. Hypertens. (2002) 20 S11-S19.
18. Moser M. Current recommendations for initial therapy in hypertension: are they still valid? Introduction. Am. J. Hypertens. (1998) 11 69S-72S.
19. Moser M., Black H.R. The role of combination therapy in the treatment of hypertension. Am. J. Hypertens. (1998) 11 73S-78S.
20. Weir M.R. The rationale for combination versus single-entity therapy in hypertension. Am. J. Hypertens. (1998) 11 163S-169S.
21. Suzuki H., Moriwaki K., Kanno Y., Nakamoto H., Okada H., Chen X.M. Comparison of the effects of an ACE inhibitor and αβ-blocker on the progression of renal failure with left ventricular hypertrophy: preliminary report. Hypertens. Res. (2001) 24 153-158.
22. Waeber B., Detry J.M., Dahlof B. et al. Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy? Am. J. Hypertens. (1999) 12 915-920.
23. Menard J. Critical assessment of combination therapy development. Blood Press. Suppl. (1993) 1 5-9.
24. Deanfield J.E., Detry J.M., Sellier P. et al. CAPE II Trial Investigators. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial. J. Am. Coll. Cardiol. (2002) 40 917-925.
25. Davles R.F., Habibi H., Klinke W.P. et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J. Am. Coll. Cardiol. (1995) 25 619-625.
26. Mettimano M., Pichetti F., Fazzari L, et al. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension. Int. J. Clin. Pract. (2000) 54 424-428.
27. Parati G., Lantelme P. Blood pressure variability, target organ damage and cardiovascular events. J. Hypertens. (2002) 20 1725-1729.
28. Jokiniitty J.M., Majahalme S.K., Kahonen M.A., Tuomisto M.T., Turjanmaa V.M. Prediction of blood pressure level and need for antihypertensive medication: 10 years of follow-up. J. Hypertens. (2001) 19 1193-1201.
29. Sander D., Kukla C., Klingelhofer J., Winbeck K., Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation (2000) 102 1536-1541.
30. Stopher D.A., Beresford A.P., Macrae P.V., Humphrey M.J. The metabolism and pharmacokinetics of amlodipine in humans and animals. J. Cardiovasc. Pharmacol. (1988) 12(Suppl. 7) S55-S59.
31. Deanfield J.E., Detry J.M., Sellier P, et al. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial. J. Am. Coll. Cardiol. (2002) 40 917-925.